The NCI comprehensive consortium uniting Case Western Reserve University, University Hospitals Seidman Cancer Center and Cleveland Clinic.
NCI-designated since 1987 and comprehensive since 1998, Case Comprehensive Cancer Center is a consortium of Case Western Reserve University, University Hospitals Seidman Cancer Center and Cleveland Clinic's Taussig Cancer Institute. Sanford Markowitz's colon cancer genetics (TGF-beta receptor II inactivation, 15-PGDH) led to stool methylated-DNA screening markers and chemoprevention concepts; UH Seidman opened a compact Mevion proton centre in 2016. The consortium offers patients across north-east Ohio a shared portfolio of NCI cooperative group and investigator-initiated trials, and its members include Cleveland Clinic's Lerner Research Institute.
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-10-01.
Matched to Case Comprehensive Cancer Center, including child institutions. 283 works · 7,189 citations · 70% open access · 9% clinical trials · 1% reviews.
Shares Mevion Medical Systems, Proton therapy.
Shares DNA methylation profiling, Proton therapy.
Shares Colorectal cancer screening (colonoscopy, FIT, stool DNA, blood), DNA methylation profiling, Colorectal cancer.
Shares Colorectal cancer screening (colonoscopy, FIT, stool DNA, blood), Colorectal cancer.
Shares Colorectal cancer screening (colonoscopy, FIT, stool DNA, blood), Colorectal cancer.
Shares Colorectal cancer screening (colonoscopy, FIT, stool DNA, blood), National Cancer Institute (NIH), Colorectal cancer.
Shares Colorectal cancer screening (colonoscopy, FIT, stool DNA, blood), DNA methylation profiling, Colorectal cancer.